Szczepionki przeciwko pryszczycy

• Autorzy: Paprocka G.

Warianty tytułu

EN

Foot-and-mouth disease vaccines

• Języki publikacji: PL

Abstrakty

EN

Foot-and-mouth disease (FMD) is considered one of the most contagious and economically devastating diseases affecting cloven-hoofed livestock worldwide. The etiologic agent, FMD virus (FMDV), has a positive-sense, single-stranded RNA genome, and belongs to the genus Aphthovirus in the family Picornaviridae. FMDV is antigenically variable and consists of seven serotypes (A, O, C, Asia 1, SAT 1, SAT 2, SAT 3) and more than 60 subtypes. Antigenic diversity of FMDV is a major concern for FMD control. An important part of controlling and prevention of foot and mouth disease are still conventional inactivated vaccines. Vaccines against FMD are of major importance in endemic regions for controlling the disease, they are also important as emergency vaccines to limit the spread of outbreaks in FMD-free countries. Inactivated FMD preparations have been used successfully as part of eradication programs. However there are many problems and limitations associated with their use. In order to solve them a new generation vaccines is being developed. The article presents various types of FMD vaccines such as inactivated vaccines, subunit vaccines, live vector vaccines, DNA vaccines and live attenuated vaccines.

Słowa kluczowe

PL

choroby zwierzat; choroby wirusowe; pryszczyca; zwalczanie chorob zwierzat; szczepienia ochronne; szczepionki przeciw pryszczycy; szczepionki inaktywowane; szczepionki podjednostkowe; szczepionki zywe wektorowe; szczepionki DNA; szczepionki zywe atenuowane

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2013
• Tom: 69
• Numer: 11
• Opis fizyczny: s.643-648,bibliogr.

Twórcy

autor

Paprocka G.

• Zakład Pryszczycy, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy w Puławach, ul.Wodna 7, 98-220 Zduńska Wola

Bibliografia

• 1. Bachrach H. L.: Foot-and-mouth disease. Annu. Rev. Microbiol. 1968, 22, 201-244.
• 2. Bachrach H. L., Moore D. M., McKercher P. D., Polatnick J.: Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J. Immunol. 1975, 115, 1636-1641.
• 3. Balamurugan V., Renji R., Saha S. N., Reddy G. R., Gopalakrishna S., Suryanarayana V. V.: Protective immune response of the capsid precursor polypeptide (P1) of foot-and-mouth disease virus type „O” produced in Pichia pastoris. Virus Res. 2003, 92, 141-149.
• 4. Berinstein A., Tami C., Taboga O., Smitsaart E., Carrillo E.: Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. Vaccine 2000, 18, 2231-2238.
• 5. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F.: Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 1982, 298, 30-33.
• 6. Brooksby J. B.: Portraits of viruses: foot-and-mouth disease virus. Intervirology 1982, 18, 1-23.
• 7. Capstick P. B., Telling R. C., Chapman W. G., Stewart D. L.: Growth of a cloned strain of hamster kidney cells in suspended culture and their susceptibility to the virus of foot-and-mouth disease. Nature 1962, 195, 1163-1164.
• 8. Carrillo C., Wigdorovitz A., Oliveros J. C., Zamorano P. I., Sadir A. M., Gómez N., Salinas J., Escribano J. M., Borca M. V.: Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J. Virol. 1998, 72, 1688-1690.
• 9. Carrillo C., Wigdorovitz A., Trono K., Dus Santos M. J., Castañón S., Sadir A. M., Ordas R., Escribano J. M., Borca M. V.: Induction of a virus-specific antibody response to foot-and-mouth disease virus using the structural proteinVP1 expressed in transgenic potato plants. Viral Immunol. 2001, 14, 49-57.
• 10. Cedillo-Barron L., Foster-Cuevas M., Belsham G. J., Lefevre F., Parkhouse R. M. E.: Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D polymerase. J. Gen. Virol. 2001, 82, 1713-1724.
• 11. Chinsangaram J., Beard C., Mason P. W., Zellner M. K., Ward G., Grubman M. J.: Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J. Virol. 1998, 72, 4454-4457.
• 12. Chinsangaram J., Mason P. W., Grubman M. J.: Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 1998, 16, 1516-1522.
• 13. Cubillos C., de la Torre B. G., Jakab A., Clementi G., Borras E., Barcena J., Andreu D., Sobrino F., Blanco E.: Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge inducted by a novel dendrimeric peptide. J. Virol. 2008, 82, 7223-7230.
• 14. DeClerq K., Goris N., Barnett P. V., MacKay D. K.: The importance of quality assurance/quality control of diagnostics to increase the confidence in global foot-and-mouth disease control. Transbound Emerg. Dis. 2008, 55, 35-45.
• 15. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N.: Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 1986, 232, 639-641.
• 16. Doel T. R.: FMD vaccines. Virus Res. 2003, 91, 81-99.
• 17. Fowler V., Robinson L., Bankowski B., Cox S., Parida S., Lawlor C., Gibson D., O’Brien F., Ellefsen B., Hannaman D., Takamatsu H. H., Barnett P. V.: A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease. Antiviral Res. 2012, 94, 25-34.
• 18. Graham F. L., Smiley J., Russel W. C., Nairn R.: Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 1977, 36, 59-74.
• 19. Grubman M. J., Moraes M. P., Schutta C., Barrera J., Neilan J., Ettyreddy D., Butman B. T., Brough D. E., Brake D. A.: Adenovirus serotype 5-vectored foot-and-mouth disease subunit vaccines: the first decade. Future Virol. 2010, 5, 51-64.
• 20. Grubman M. J., Zellner M., Bablanian G., Mason P. W., Piccone M. E.: Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology 1995, 213, 581-589.
• 21. Kleid D. G., Yansura D., Small B., Dowbenko D., Moore D. M., Grubman M. J., McKercher P. D., Morgan D. O., Robertson B. H., Bachrach H. L.: Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 1981, 214, 1125-1129.
• 22. Li X., Liu R., Tang H., Jin M., Chen H., Qian P.: Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Vaccine 2008, 26, 2714-2722.
• 23. Li Y., Stirling C., Denyer M., Hamblin P., Hutchins G., Takamatsu H., Barnett P.: Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost. Vaccine 2008, 26, 2647-2656.
• 24. Lombard M., Pastoret P. P., Moulin A. M.: A brief history of vaccines and vaccination. Rev. sci. tech. Off. int. Epiz. 2007, 26, 29-48.
• 25. Ma M., Jin N., Shen G., Zhu G., Liu H. J., Zheng M., Lu H., Huo X., Jin M., Yin G., Ma H., Li X., Ji Y., Jin K.: Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18. Vet. Immunol. Immunopathol. 2008, 121, 1-7.
• 26. Mayr G. A., O’Donnell V., Chinsangaram J., Mason P. W., Grubman M. J.: Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine 2001, 19, 2152-2162.
• 27. McKenna T. S., Lubroth J., Rieder E., Baxt B., Mason P. W.: Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J. Virol. 1995, 69, 5787-5790.
• 28. Meloen R. H., Casal J. I., Dalsgaard K., Langeveld J. P.: Synthetic peptide vaccines: success at last. Vaccine 1995, 13, 885-886.
• 29. Moraes M. P., Chinsangaram J., Brum M. C., Grubman M. J.: Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 2003, 22, 268-279.
• 30. Moraes M. P., Diaz-San Segundo F., Dias C. C., Pena L., Grubman M. J.: Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. Vaccine 2011, 29, 9431-9440.
• 31. Moraes M. P., Mayr G. A., Mason P. W., Grubman M. J.: Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 2002, 20, 1631-1639.
• 32. Mowat G. N., Chapman W. G.: Growth of foot-and-mouth disease virus in a fibroblastic cell line derived from hamster kidneys. Nature 1962, 194, 253-255.
• 33. Niborski V., Li Y., Brennan F., Lane M., Torché A. M., Remond M., Bonneau M., Riffault S., Stirling C., Hurchings G., Takamatsu H., Barnett P., Charley B., Schwartz-Cornil I.: Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV. Vaccine 2006, 24, 7204-7213.
• 34. Pacheco J. M., Brum M. C., Moraes M. P., Golde W. T., Grubman M. J.: Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 2005, 337, 205-209.
• 35. Parida S.: Vaccination against foot-and-mouth disease virus: strategies and effectiveness. Expert Rev. Vaccines 2009, 8, 347-365.
• 36. Prevec L., Schneider M., Rosenthal K. L., Belbeck L. W., Derbyshire J. B., Graham F. L.: Use of human adenovirus-based vectors for antigen expression in animals. J. Gen. Virol. 1989, 70, 429-434.
• 37. Roosien J., Belsham G. J., Ryan M. D., King A. M., Vlak J. M.: Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J. Gen. Virol. 1990, 71, 1703-1711.
• 38. Taboga O., Tami C., Carrillo E., Núñez J. I., Rodriguez A., Saiz J. C., Blanco E., Valero M. L., Roig X., Camarero J. A., Andreu D., Mateu M. G., Giralt E., Domingo E., Sobrino F., Palma E. L.: A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 1997, 71, 2606-2614.
• 39. Vidal M., Cairo J., Mateu M. G., Villaverde A.: Molecular cloning and expression of the VP1 gene of foot-and-mouth disease virus C1 in E. coli: effect on bacterial cell viability. Appl. Microbiol. Biotechnol. 1991, 35, 788-792.